Immunovant (IMVT) Exchange Rate Effect (2021 - 2026)
Immunovant (IMVT) posted Exchange Rate Effect of -$988000.0 for Q1 2026, down 362.07% on a QoQ basis from $377000.0 in Q4 2025, and down 102.46% year-over-year from $40.2 million in Q1 2025.
Immunovant (IMVT) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Immunovant's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$988000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 102.46% year-over-year to -$988000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$299000.0 (down 140.03% YoY) and the FY2026 annual result came in at -$299000.0, down 140.03% from the prior year.
- Exchange Rate Effect was -$988000.0 for Q1 2026 at Immunovant, down from $377000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.7 million in Q1 2024 and bottomed at -$1.6 million in Q4 2023.
- A 5-year average of $91117.6 and a median of -$112000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 13385.0% — and 2023, when it sank 337.5%.
- Immunovant's Exchange Rate Effect stood at $2.7 million in 2022, then slumped by 159.55% to -$1.6 million in 2023, then jumped by 90.72% to -$149000.0 in 2024, then jumped by 353.02% to $377000.0 in 2025, then slumped by 362.07% to -$988000.0 in 2026.
- Business Quant data shows IMVT's Exchange Rate Effect at -$988000.0 in Q1 2026, $377000.0 in Q4 2025, and $878000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -988,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -988,000.00 |
| Mar 31, 2026 | -988,000.00 |
| Dec 31, 2025 | 377,000.00 |
| Dec 31, 2025 | 377,000.00 |
| Sep 30, 2025 | 878,000.00 |
| Sep 30, 2025 | 878,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Mar 31, 2025 | -488,000.00 |
| Mar 31, 2025 | -488,000.00 |
| Dec 31, 2024 | -149,000.00 |
| Dec 31, 2024 | -149,000.00 |
| Sep 30, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 335,000.00 |
| Jun 30, 2024 | 335,000.00 |
| Mar 31, 2024 | 2.73 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Dec 31, 2023 | -1.61 Mn |